Ashleigh Myall on predicting hospital-onset C...

Hugo Aerts and Ray Mak from Mass General Brigham join Lucy Dunbar to discuss FaceAge, a deep learning tool that estimates biological age from simple face photographs, and its implications in aiding clinicians in predicting prognoses for people with cancer.Read the full article:ht ...  Show more

Mohamed Omar joins The Lancet Digital Health to discuss pathology and generative AI from a Digital Health Perspective. We explore expert journeys, AI applications in diagnostics, GPT-4's role, integration challenges, ethical considerations, democratisation of knowledge, and futur ...  Show more

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles: https://www.thelancet.com/ ...  Show more

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more

In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ...  Show more

Join EHA President prof. Konstanze Döhner from University Hospital Ulm in Germany who discusses the most recent developments in the management of young and fit patients with AML. Tune in to hear about the diagnostic workup, risk stratification, treatment and the evolving role of ...  Show more